1371608-36-4

Basic information

• Product Name: 3-methyl-4-((R)-2-oxo-5-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile
• Synonyms: 3-methyl-4-((R)-2-oxo-5-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile
• CAS NO: 1371608-36-4
• Molecular Weight: 366.263
• Mol File: 1371608-36-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-methyl-4-((R)-2-oxo-5-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-methyl-4-((R)-2-oxo-5-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile(1371608-36-4)
• EPA Substance Registry System: 3-methyl-4-((R)-2-oxo-5-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile(1371608-36-4)

Safety Data

• Hazardous Substances Data: 1371608-36-4(Hazardous Substances Data)

Upstream product

• 1371608-77-3 (R)-4-(2-(hydroxymethyl)-5-oxopyrrolidin-1-yl)-3-methyl-2-(trifluoromethyl)benzonitrile 
• 1371608-76-2 (R)-3-methyl-4-(2-oxo-5-((trityloxy)methyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile 
• 1371608-75-1 4-bromo-3-methyl-2-(trifluoromethyl)benzonitrile 
• 1371608-78-4 C₁₄H₁₁F₃N₂O₂ 
• 573764-81-5 N-(4-Cyano-2-methyl-3-trifluoromethylphenyl)-2,2-dimethyl-propionamide 
• 320-51-4 4-chloro-3-trifluoromethyl-aniline 
• 573764-86-0 4-amino-3-methyl-2-trifluoromethylbenzonitrile 
• 112641-23-3 N-(4-Chloro-2-methyl-3-trifluoromethylphenyl)-2,2-dimethyl-propionamide 
• 13691-92-4 N-(4-chloro-3-trifluoromethylphenyl)-2,2-dimethylpropionamide 

Relevant articles and documents

SELECTIVE ANDROGEN RECEPTOR MODULATORS

This invention provides compounds of formula I, pharmaceutical compositions comprising a compound of formula I and a pharmaceutically acceptable excipient, methods of modulating the androgen receptor, methods of treating diseases beneficially treated by an androgen receptor modulator (e.g., sarcopenia, prostate cancer, contraception, type 2 diabetes related disorders or diseases, anemia, depression, and renal disease) and processes for making compounds and intermediates useful in the preparation of same.